Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
1.
World J Gastrointest Oncol ; 12(10): 1195-1208, 2020 Oct 15.
Artigo em Inglês | MEDLINE | ID: mdl-33133386

RESUMO

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths worldwide, but there is a shortage of effective biomarkers for its diagnosis. AIM: To explore blood exosomal micro ribonucleic acids (miRNAs) as potential biomarkers for HCC diagnosis. RESULTS: The principal component analysis suggested that daily alcohol consumption could alter the blood exosomal miRNA profiles of hepatitis B virus positive non-HCC patients through miR-3168 and miR-223-3p. The miRNA profiles also revealed the tumor stages of HCC patients. High expression of miR-455-5p and miR-30c-5p, which significantly correlated with better overall survival in tumor tissues, could also be detected in blood exosomes. Two pairs of miRNAs (miR-584-5p/miR-106-3p and miR-628-3p/miR-941) showed a 94.1% sensitivity and 68.4% specificity to differentiate HCC patients from non-HCC patients. The specificity of the combination was substantially influenced by alcohol consumption habits. CONCLUSION: This study suggested that blood exosomal miRNAs can be used as new non-invasive diagnostic tools for HCC. However, their accuracy could be affected by tumor stage and alcohol consumption habits.

2.
J Extracell Vesicles ; 8(1): 1663666, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31579436

RESUMO

In this study, we evaluated the diagnostic value and molecular characteristics of plasma extracellular vesicles (EVs)-derived miRNAs for patients with solitary pulmonary nodules (SPNs), particularly ground-glass nodules (GGNs). This study was registered at www.clinicaltrials.gov under registration number NCT03230019. Small RNA sequencing was performed to assess plasma EVs miRNAs in 59 patients, including 12 patients with benign nodules (2017, training set). MiRNA profiles of 40 an additional individuals were sequenced (2018, validation set). Overall, 16 pure GGNs, 21 mixed GGNs, and 42 solid nodules were included, with paired post-operative plasma samples available for 20 patients. The target miRNA/reference miRNA ratio was used to construct a support vector machine (SVM) model. The SVM model with the best specificity showed 100% specificity in both the training and validation sets independently. The model with the best sensitivity showed 100% and 96.9% sensitivity in the training and validation sets, respectively. Principal component analysis revealed that pure GGN distributions were distinct from those of solid nodules, and mixed GGNs had a diffuse distribution. Among differentially expressed miRNAs, miR-500a-3p, miR-501-3p, and miR-502-3p were upregulated in tumor tissues and enhanced overall survival. The SVM classifier accurately distinguished malignant GGNs and benign nodules. The distinct profile characteristics of miRNAs provided insights into the feasibility of EVs miRNAs as prognostic factors in lung cancer.

3.
Cancer Manag Res ; 11: 3721-3739, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31118792

RESUMO

Background: Genetic factors play an important role in colorectal cancer (CRC) risk, yet the prevalence and spectrum of germline cancer susceptibility gene mutations among unselected Chinese CRC patients is largely undetermined. Methods: We performed next-generation sequencing with a 73-genes panel and analyzed the prevalence and spectrum of germline mutations in 618 unselected Chinese CRC patients. We classified all identified germline alterations for pathogenicity and calculated the frequencies of pathogenic mutations. Clinical characteristics were assessed by age and mutation status. Protein expressions and interactions of MLH1 missense variants were evaluated by western blot and co- immunoprecipitation. Results: Overall, 112 (18.1%) of 618 unselected Chinese CRC patients were found to carry at least one pathogenic or likely pathogenic variant (totaling 97 variants), including 70 (11.3%) Lynch syndrome (LS) mutation carriers and 42 (6.8%) non-LS mutation carriers. LS mutation carriers were significantly younger at CRC diagnosis and were more likely to have right-sided, poorly differentiated, early stage, high-frequency microsatellite instability (MSI-H) or dMMR CRC and a family history of cancer compared with noncarriers. Non-LS mutation carriers were more likely to be proficient mismatch repair (pMMR) than noncarriers (p=0.039). We found four clinical variables (gender, tumor histological stage, cancer stage and mutation status) that showed significant differences between patients younger and older than 50 years old. Higher mutation rates were found in patients under 50 years old (p=0.017). Thirty-three novel variants were discovered and evaluated as pathogenic mutations by our study. Conclusion: Given the high frequency and wide spectrum of mutations, genetic testing with a multigene panel should be considered for all Chinese CRC patients under 50 years old and is also needed to determine whether a gene is associated with CRC susceptibility and to promote clinical translation.

4.
Oncol Rep ; 41(1): 257-269, 2019 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-30542726

RESUMO

Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide, and current treatments exhibit limited efficacy against advanced HCC. The majority of cancer-related deaths are caused by metastasis from the primary tumor, which indicates the importance of identifying clinical biomarkers for predicting metastasis and indicating prognosis. Patient-derived cells (PDCs) may be effective models for biomarker identification. In the present study, a wound healing assay was used to obtain 10 fast-migrated and 10 slow-migrated PDC cultures from 36 HCC samples. MicroRNA (miRNA) signatures in PDCs and PDC-derived exosomes were profiled by microRNA-sequencing. Differentially expressed miRNAs between the low- and fast-migrated groups were identified and further validated in 372 HCC profiles from The Cancer Genome Atlas (TCGA). Six exosomal miRNAs were identified to be differentially expressed between the two groups. In the fast-migrated group, five miRNAs (miR-140-3p, miR-30d-5p, miR-29b-3p, miR-130b-3p and miR-330-5p) were downregulated, and one miRNA (miR-296-3p) was upregulated compared with the slow-migrated group. Pathway analysis demonstrated that the target genes of the differentially expressed miRNAs were significantly enriched in the 'focal adhesion' pathway, which is consistent with the roles of these miRNAs in tumor metastasis. Three miRNAs, miR-30d, miR-140 and miR-29b, were significantly associated with patient survival. These findings indicated that these exosomal miRNAs may be candidate biomarkers for predicting HCC cell migration and prognosis and may guide the treatment of advanced HCC.


Assuntos
Biomarcadores Tumorais/metabolismo , Carcinoma Hepatocelular/genética , Exossomos/metabolismo , Neoplasias Hepáticas/genética , MicroRNAs/metabolismo , Adulto , Idoso , Carcinoma Hepatocelular/patologia , Movimento Celular/genética , Células Cultivadas , Regulação para Baixo , Feminino , Perfilação da Expressão Gênica , Regulação Neoplásica da Expressão Gênica , Humanos , Fígado/citologia , Fígado/patologia , Neoplasias Hepáticas/mortalidade , Neoplasias Hepáticas/patologia , Masculino , Pessoa de Meia-Idade , Cultura Primária de Células , Prognóstico , Análise de Sobrevida
5.
Hellenic J Cardiol ; 58(5): 387-390, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28347792

RESUMO

Inflammation is associated with atrial fibrillation (AF), and peroxisome proliferator-activated receptor-gamma (PPARγ) agonists have anti-inflammatory properties. We tested whether pioglitazone reduced AF recurrence after electrical cardioversion (EC) by modifying systemic inflammation. In this randomized and prospective trial, patients with persistent AF and type 2 diabetes mellitus were randomized into a pioglitazone group (n=48) or a control group (n=49) before EC. Treatment was continued for 3 months or until AF recurred. Serum inflammatory markers [high sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6) and tumour necrosis factor-α (TNF-α)] were measured at baseline and follow-up. During the 3-month follow-up, AF recurred in 22 (45.8%) patients of the pioglitazone-treated and 24 (49.0%) patients of the control group (P=0.756). However, the 3 inflammatory markers were significantly lowered with pioglitazone treatment during follow-up. Cox proportional hazards regression models showed that the predictors of recurrence included AF history (relative risk RR 1.002, 95% CI 1.003-1.061, P =0.037) and the left atrial diameter (RR 1.131, 95% CI 1.029-1.242, P = 0.010). In conclusion, while reducing some inflammatory markers, the PPARγ agonist pioglitazone did not affect the recurrence of AF after EC.


Assuntos
Fibrilação Atrial/terapia , Diabetes Mellitus Tipo 2/complicações , Cardioversão Elétrica/métodos , PPAR gama/agonistas , Tiazolidinedionas/uso terapêutico , Fibrilação Atrial/complicações , Diabetes Mellitus Tipo 2/tratamento farmacológico , Feminino , Seguimentos , Humanos , Hipoglicemiantes/uso terapêutico , Masculino , Pessoa de Meia-Idade , Pioglitazona , Recidiva , Estudos Retrospectivos , Resultado do Tratamento
6.
World J Gastroenterol ; 22(46): 10254-10259, 2016 Dec 14.
Artigo em Inglês | MEDLINE | ID: mdl-28028375

RESUMO

Gallbladder cancer (GBC), although considered as a relatively rare malignancy, is the most common neoplasm of the biliary tract system. The late diagnosis and abysmal prognosis present challenges to treatment. The overall 5-year survival rate for metastatic GBC patients is extremely low. BRCA1 and BRCA2 are the breast cancer susceptibility genes and their mutation carriers are at a high risk for cancer development, both in men and women. Olaparib, an oral poly ADP-ribose polymerase inhibitor, has been approved by the Food and Drug Administration and the European Commission for the treatment of ovarian cancer with any BRCA1/2 mutations. The first case of a BRCA1-mutated GBC patient who responded to olaparib treatment is reported here.


Assuntos
Antineoplásicos/uso terapêutico , Neoplasias da Vesícula Biliar/tratamento farmacológico , Genes BRCA1 , Neoplasias Hepáticas/tratamento farmacológico , Ftalazinas/uso terapêutico , Piperazinas/uso terapêutico , Idoso , Neoplasias da Vesícula Biliar/diagnóstico por imagem , Neoplasias da Vesícula Biliar/genética , Neoplasias da Vesícula Biliar/patologia , Humanos , Neoplasias Hepáticas/diagnóstico por imagem , Neoplasias Hepáticas/genética , Neoplasias Hepáticas/secundário , Masculino , Mutação , Tomografia Computadorizada por Raios X , Resultado do Tratamento
7.
Int Immunopharmacol ; 32: 1-7, 2016 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-26774212

RESUMO

Resveratrol (RSV) has many biological effects, including antitumor and antiviral activities, and vascular protection. Recent studies have suggested that RSV exerts its antitumor effects through induction of autophagy by an unknown mechanism. Doxorubicin (DOX) is a wide spectrum antitumor drug, but its clinical application is limited by its cardiotoxicity. This study evaluated whether the manipulation of autophagy could attenuate the cardiotoxic effects of DOX in vitro as well as in a rat model of DOX-induced cardiotoxicity. We found that DOX induced H9C2 cell apoptosis by inhibiting AMPK activation and promoting pro-apoptotic protein expression through p38MAPK/p53 signaling. RSV-treated H9C2 cells showed increased autophagy through the AMPK/mTOR/Ulk1 pathway. When DOX and RSV were combined, apoptosis was decreased, despite a slight increase in the autophagy ratio. The same result was observed in the rat model of DOX-induced cardiotoxicity. Injection with DOX or RSV alone, or in combination, for a week, resulted in a reduced apoptotic ratio in the combination group compared with the DOX alone group. Our results strongly indicate that this co-treatment strategy with RSV can attenuate the cardiotoxic effects of DOX. Our findings may have important clinical implications.


Assuntos
Antibióticos Antineoplásicos/efeitos adversos , Cardiotoxicidade/tratamento farmacológico , Doxorrubicina/efeitos adversos , Estilbenos/uso terapêutico , Proteínas Quinases Ativadas por AMP/metabolismo , Animais , Autofagia/efeitos dos fármacos , Cardiotoxicidade/metabolismo , Linhagem Celular , Sobrevivência Celular/efeitos dos fármacos , Ratos Sprague-Dawley , Resveratrol , Estilbenos/farmacologia
8.
J Cell Mol Med ; 19(10): 2324-8, 2015 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-26177159

RESUMO

Doxorubicin is the mainstay of treatment for various haematological malignancies and solid tumours. However, its clinical application may be hampered by dose-dependent cardiotoxicity. The mechanism of doxorubicin-induced cardiotoxicity may involve various signalling pathways including free radical generation, peroxynitrite formation, calcium overloading, mitochondrial dysfunction and alteration in apoptosis and autophagy. Interestingly, the use of resveratrol in combination with doxorubicin has been reported to prevent cardiac toxicity as well as to exert a synergistic effect against tumour cells both in vivo and in vitro. Thus, the aim of this review is to summarize current knowledge and to elucidate the protective effect of resveratrol in doxorubicin-induced cardiotoxicity.


Assuntos
Cardiotônicos/uso terapêutico , Cardiotoxicidade/tratamento farmacológico , Doxorrubicina/efeitos adversos , Sesquiterpenos/uso terapêutico , Estilbenos/uso terapêutico , Animais , Cardiotônicos/farmacologia , Cardiotoxicidade/patologia , Humanos , Miócitos Cardíacos/efeitos dos fármacos , Miócitos Cardíacos/patologia , Resveratrol , Sesquiterpenos/farmacologia , Estilbenos/farmacologia , Fitoalexinas
9.
J Mol Cell Cardiol ; 65: 1-8, 2013 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-24100253

RESUMO

It has been demonstrated that atrial remodeling contributes toward atrial fibrillation (AF) maintenance and angiotensin II (AngII) is involved in the pathogenesis of atrial remodeling. Peroxisome proliferator-activated receptor-γ (PPAR-γ) agonists have been shown to inhibit atrial remodeling. However, the underlying mechanisms are poorly understood. In the present study we investigated the regulating effects of PPAR-γ agonist on AngII-induced atrial structural and electrical remodeling in vitro cellular models. The effects of pioglitazone on AngII-induced connective tissue growth factor (CTGF) expression and cell proliferation were assessed in primary-cultured mouse atrial fibroblasts. The influences of pioglitazone on AngII-induced L-type calcium channel (ICa-L) α1c expression and current density were evaluated in atrial myocytes (HL-1). Pioglitazone attenuated AngII-induced CTGF expression and proliferation in atrial fibroblasts, and pioglitazone also inhibited the expression or phosphorylation of AngII-induced transforming growth factor-ß1 (TGF-ß1), tumor necrosis factor receptor associated factor 6 (TRAF6), TGF-ß-associated kinase 1 (TAK1) and Smad2/3. In HL-1 cells, pioglitazone suppressed AngII-induced ICa-L α1c expression and current density as well as CAMP responsive element binding protein (CREB) phosphorylation. Besides, pioglitazone inhibited AngII-induced production of AngII type I receptor (AT1R) and downregulation of PPAR-γ in both atrial fibroblasts and HL-1 cells. In conclusion, Pioglitazone suppresses AngII-induced CTGF expression and proliferation in atrial fibroblasts, which might be at least in part related with its inhibitory effects on TGF-ß1/Smad2/3 and TGF-ß1/TRAF6/TAK1 signaling pathways. Moreover, pioglitazone also attenuates AngII-induced ICa-L remodeling in HL-1 cells, which might be at least in part associated with its inhibitory effect on CREB phosphorylation. It is suggested that PPAR-γ agonist may have potential applications in preventing atrial remodeling.


Assuntos
Remodelamento Atrial/efeitos dos fármacos , Cardiotônicos/farmacologia , Átrios do Coração/patologia , Átrios do Coração/fisiopatologia , Modelos Biológicos , Tiazolidinedionas/farmacologia , Angiotensina II , Animais , Proliferação de Células/efeitos dos fármacos , Proteína de Ligação ao Elemento de Resposta ao AMP Cíclico/metabolismo , Fenômenos Eletrofisiológicos , Fibroblastos/efeitos dos fármacos , Fibroblastos/metabolismo , Fibroblastos/patologia , Átrios do Coração/efeitos dos fármacos , Ativação do Canal Iônico/efeitos dos fármacos , MAP Quinase Quinase Quinases/metabolismo , Masculino , Camundongos , Camundongos Endogâmicos C57BL , PPAR gama/metabolismo , Fosforilação/efeitos dos fármacos , Fosfosserina/metabolismo , Pioglitazona , Subunidades Proteicas/metabolismo , Receptor Tipo 1 de Angiotensina/metabolismo , Transdução de Sinais/efeitos dos fármacos , Proteínas Smad/metabolismo , Fator 6 Associado a Receptor de TNF/metabolismo , Fator de Crescimento Transformador beta1/metabolismo
11.
Cardiovasc Toxicol ; 12(4): 341-9, 2012 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-22763982

RESUMO

Doxorubicin (DOX) has been used in a variety of human malignancies for decades, in particular of lymphoma. But increased cardiomyocyte apoptosis has been implicated in its cardiotoxicity. Resveratrol (RES) generates cardiovascular protective effects by heme oxygenase-1(HO-1)-mediated mechanism. The present study was designed to determine whether RES protected cardiomyocyte against apoptosis through induction of HO-1 in lymphoma nude mouse in vivo. After being developed into lymphoma model, 40 male Balb/c nude mice were randomized to one of the following four treatments (10 mice per group): control, DOX, DOX + RES and DOX + RES + HO-1 inhibitor (zinc protoporphyrin IX, ZnPP). The results showed that DOX injection markedly decreased the body weight, the heart weight and the ratio of heart weight to body weight, but inversely increased cardiomyocyte apoptosis and the level of serum lactate dehydrogenase and creatine kinase. Moreover, DOX injection attenuated HO-1 expression and enzymatic activity as well as increased P53 expression, modulated Bcl-2/Bax expression and enhanced caspase 3 activity. These cardiotoxic effects of DOX were ameliorated by its combination with RES. However, the protective effects of RES were reversed by the addition of ZnPP. Taken together, it is concluded that HO-1 plays a core role for protective action of RES in DOX-induced cardiomyocyte apoptosis in lymphoma nude mice.


Assuntos
Apoptose/efeitos dos fármacos , Linfoma de Burkitt/enzimologia , Doxorrubicina/toxicidade , Heme Oxigenase-1/biossíntese , Proteínas de Membrana/biossíntese , Miócitos Cardíacos/enzimologia , Estilbenos/farmacologia , Animais , Apoptose/fisiologia , Linfoma de Burkitt/tratamento farmacológico , Linhagem Celular Tumoral , Doxorrubicina/antagonistas & inibidores , Indução Enzimática/efeitos dos fármacos , Indução Enzimática/fisiologia , Humanos , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Nus , Miócitos Cardíacos/efeitos dos fármacos , Distribuição Aleatória , Resveratrol , Estilbenos/uso terapêutico , Ensaios Antitumorais Modelo de Xenoenxerto/métodos
12.
Theor Appl Genet ; 118(1): 29-41, 2008 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-18787805

RESUMO

Aluminum (Al) toxicity is a major constraint for wheat production in acidic soils. Wheat producers now routinely use Al-resistant cultivars as one cost-effective means to reduce risks associated with acidic soils. To date, diverse Al-resistant materials have been identified, but their genetic relationship has not been well characterized. A total of 57 wheat accessions, including the majority of the parents of Al-resistant accessions we identified in a previous study, were evaluated for Al resistance and analyzed with 49 simple sequence repeat (SSR) markers and 4 markers for Al-activated malate transporter (ALMT1). Pedigree and principle coordinate analysis (PCA) both separated Al-resistant accessions into four groups labeled according to common ancestry or geographical origin: US-Fultz, Polyssu, Mexican and Chinese. Al resistance in the four groups may have three independent origins given their distinct geographic origins and gene pools. Fultz originated in the USA as a major ancestor to soft red winter wheat, Polyssu originated in Brazil as a major source of Al resistance used in most genetic studies worldwide, and the Chinese group originated in China. Based on ALMT1 marker haplotypes, the Al resistance in the Polyssu and Mexico groups was likely derived from Polyssu, while most Al-resistant cultivars developed in the USA most likely inherited most of Al resistance from Fultz. Fultz was released about 50 years earlier than Polyssu. Norin 10 likely played a pivotal role in passing Al-resistant gene(s) from Fultz to better adapted, semi-dwarf wheat cultivars developed in the USA. Further characterization of Al resistance in the three different sources could reveal multiple Al-resistant mechanisms in wheat.


Assuntos
Alumínio/toxicidade , Evolução Molecular , Triticum/genética , Brasil , China , DNA de Plantas/genética , Marcadores Genéticos , Variação Genética , Haplótipos , Repetições Minissatélites , Raízes de Plantas/efeitos dos fármacos , Raízes de Plantas/genética , Poluentes do Solo/toxicidade , Triticum/efeitos dos fármacos , Estados Unidos
13.
Artigo em Chinês | MEDLINE | ID: mdl-16361795

RESUMO

The effects of high temperature on grain filling rate and some physiological indexes in flag leaves in hybrid rice Teyou 559 were studied. The results showed that chlorophyll content and superoxide dismutase (SOD) activity in flag leaves were lower significantly by high temperature stress (Figs.2A and 3A). The electrolyte leakage and malondialdehyde (MDA) content were higher significantly under high temperature stress (Figs.2B and 3B). The proline (Pro), ascorbic acid (AsA), glutathione (GSH), soluble protein and soluble sugar contents were lower significantly by high temperature stress than those of the control (Figs.4,5 and 6). Both the rate of grain filling and grain dry matter accumulation become lower significantly under high temperature stress (Figs.7 and 8). Therefore, it was suggested that high temperature accelerated the senescence of rice leaf and decreased the photosynthesis rate during grain filling period, and then which was the main reason in physiology which resulted the decrease of grain filling rate, seed setting rate, grain weight and yield.


Assuntos
Grão Comestível/metabolismo , Temperatura Alta , Oryza/metabolismo , Folhas de Planta/metabolismo , Ácido Ascórbico/metabolismo , Clorofila/metabolismo , Grão Comestível/genética , Grão Comestível/fisiologia , Glutationa/metabolismo , Hibridização Genética , Malondialdeído/metabolismo , Oryza/genética , Oryza/fisiologia , Fotossíntese/fisiologia , Folhas de Planta/genética , Folhas de Planta/fisiologia , Prolina/metabolismo , Superóxido Dismutase/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA